Adenosine A3 agonists reverse neuropathic pain via T cell–mediated production of IL-10 is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Saint Louis University
Grant: Start Up funds
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: ZIADK031117,ZIADK075063
Università degli Studi di Firenze
Grant: Fondi Ateneo
Fondazione Umberto Veronesi
Grant: FUV2020-3299
Intramural NIH HHS
Grant: ZIA DK031117
Intramural NIH HHS
Grant: ZIA DK075063
FWCI
7.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 3 of Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice
Additional file 3 of Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice